Navigation Links
Simple test accurately predicts risk of serious jaundice in newborns
Date:1/10/2008

Philadelphia, Pa., Jan. 10, 2008 A simple test can accurately identify which newborn babies are at risk for developing dangerous levels of jaundice, according to researchers at The Childrens Hospital of Philadelphia.

While neonatal jaundice, a yellowing of the skin caused by a buildup of a blood product called bilirubin, is common in newborns and usually disappears on its own, it can progress to brain damage in a small fraction of cases.

The American Academy of Pediatrics currently recommends two options, used alone or in combination, to assess an infants risk of developing severe hyperbilirubinemia: a predischarge measurement of the bilirubin level and a screening checklist of risk factors such as intended method of feeding, siblings with history of jaundice, and race.

The Children's Hospital researchers say that the predischarge bilirubin measurement, combined with the baby's gestational age, is the most accurate method for predicting whether the newborn is at risk.

Their findings are published in the January 2008 issue of the journal Pediatrics. Childrens Hospital physicians studied outcomes for 823 newborns admitted to the Hospital of the University of Pennsylvania in Philadelphia between September 2004 and October 2005.

The challenge facing every pediatrician who takes care of newborn babies is to identify those infants they send home that will develop a bilirubin level that could cause injury, said Ron Keren, M.D., M.P.H., a pediatrician at Childrens Hospital and the lead author of the study. We found that by measuring the bilirubin in every baby, and combining that information with the babys gestational age, you could accurately predict which infants are at very high risk and which ones are at very low risk.

This screening method should allow pediatricians to determine which newborns should stay in the hospital for monitoring, which may go home and return the next day for another test and which dont need any additional follow-up for jaundice. About 70 percent of babies fell into the low-risk category, while 13 percent were designated high risk and 17 percent were in the middle, said Keren.

It did a nice job of pulling out a very large group of babies you dont have to worry about and a small group of babies that need to be closely followed, Keren said.

About four million babies are born in the U.S. each year. Of those, about 60 percent will develop jaundice in the first few days of life, but only about 1 in 100,000 will develop bilirubin levels that cause brain damage, known as kernicterus.

The authors caution that the study has a few limitations, including a small sample size. Some infants in the study were treated with phototherapy, high levels of colored light used to break down the bilirubin, before meeting the criteria. Finally, about half of the study participants were born to black mothers and the researchers data indicates black infants are less prone to develop significant hyperbilirubinemia.

More research on risk-assessment strategies is needed to weigh the cost of implementing a universal program and its effectiveness for preventing severe hyperbilirubinemia against false test results, unnecessary testing and treatment, and delay in hospital discharge, said Keren.


'/>"/>

Contact: Juliann Walsh
walshj1@email.chop.edu
267-426-6054
Children's Hospital of Philadelphia
Source:Eurekalert

Related medicine news :

1. Ring In 2008 With Simple New Years Resolutions That Will Stick Year-Round
2. Simple strategy could prevent half of deadly tuberculosis infections
3. be(R) is Making Health Simple With Complimentary, Expert Online Diet, Nutrition and Exercise Advice
4. YMCA of the USA Offers Simple Tips to Give the Lifetime Gift of Health and Well-Being to Family and Friends This Holiday Season
5. Simple Tips Keep the Flu at Bay
6. LA BioMed research finds simpler way to assess breast cancer risk
7. Six Simple Steps to Protect Against and Stop the Spread of Superbugs
8. Simpler Anemia Treatment May Help Kidney Patients
9. Simplex Diabetic Supply, Inc. Secures $50 Million in Growth Equity from New Enterprise Associates
10. AUDIO from Medialink and Bayer: Simple, Focused Ways to Boost Womens Health
11. Simple, personalized interventions improve colorectal cancer screening rates
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... ... 2016 , ... Quality metrics are proliferating in cancer care, and are derived ... eye of the beholder, according to experts who offered insights and commentary in the ... Care. For the full issue, click here . , For the American Society ...
(Date:6/26/2016)... ... June 26, 2016 , ... PawPaws brand pet supplements ... was developed to enhance the health of felines. The formula is all-natural and is ... herbs in the PawPaws Cat Kidney Support Supplement Soft Chews are Astragalus ...
(Date:6/25/2016)... ... June 25, 2016 , ... Experts from the American ... Annual Research Meeting June 26-28, 2016, at the Hynes Convention Center in Boston. ... including advance care planning, healthcare costs and patient and family engagement. , AIR ...
(Date:6/25/2016)... ... June 25, 2016 , ... "With 30 hand-drawn hand gesture ... said Christina Austin - CEO of Pixel Film Studios. , ProHand Cartoon’s package ... Final Cut Pro X . Simply select a ProHand generator and drag it ...
(Date:6/25/2016)... ... June 25, 2016 , ... ... recover from injury. Recently, he has implemented orthobiologic procedures as a method for ... is one of the first doctors to perform the treatment. Orthobiologics are substances ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... June 23, 2016 Roche (SIX: RO, ROG; ... for its Elecsys BRAHMS PCT (procalcitonin) assay as a ... septic shock. With this clearance, Roche is the first ... integrated solution for sepsis risk assessment and management. ... infection and PCT levels in blood can aid clinicians ...
(Date:6/23/2016)... Capricor Therapeutics, Inc. ... company focused on the discovery, development and commercialization ... in its ongoing randomized HOPE-Duchenne clinical trial (Halt ... its 24-patient target. Capricor expects the trial to ... 2016, and to report top line data from ...
(Date:6/23/2016)... -- Bracket , a leading clinical trial technology and ... platform, Bracket eCOA (SM) 6.0, at the 52 nd ... 2016 in Philadelphia , Pennsylvania.  A demonstration ... of its kind to fully integrate with RTSM, will be ... is a flexible platform for electronic clinical outcomes assessments that ...
Breaking Medicine Technology: